A new reality in genetic medicine lies ahead, one that will be ushered in with the advent of safe, effective, and redosable nucleic acid delivery technologies. At Entos, we develop next generation genetic medicines using our proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated with FAST proteins toenable the delivery of nucleic acid into target cells through direct fusion. For more information, visit www.entospharma.com, or follow Entos on Twitter or LinkedIn.

Biotechnology

Health Care

Life Sciences

Pharmaceutical

Entos Pharmaceuticals

Entos Pharmaceuticals' headquarters in Edmonton, Canada

Description

People (8)

Jobs (0)

Other offices